Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Ethnicity & Disease
|
February 5, 2016
The Effects of Job Instability and Financial Strain on C-Reactive Protein in a Sample of Mexican Immigrants
Patrick R Steffen, Jill Walker, Richard Meredith, et al.
Open Research Europe
|
April 24, 2024
Machine vision situations: Tracing distributed agency
Marianne Gunderson, Ragnhild Solberg, Linda Kronman, et al.
Plos One
|
June 24, 2014
Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour
James L Sherwood, Susanne Müller, Maria C M Orr, et al.
The Journal of General Virology
|
September 3, 2013
Pharmacological disruption of hepatitis C NS5A protein intra- and intermolecular conformations
Dipankar Bhattacharya, Israrul H Ansari, Robert Hamatake, et al.
Diagnostic Pathology
|
July 26, 2018
Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay
Paul Scorer, Marietta Scott, Nicola Lawson, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody, Yiduo Zhang, Marc Ballas, et al.
Clinical and Translational Science
|
November 26, 2025
Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants
Qianwen Wang, Ahmed Nader, Amanda Peppercorn, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2014
Case series of rash associated with influenza B in school children
Danuta M Skowronski, Catharine Chambers, William Osei, et al.
Clinical Lung Cancer
|
October 14, 2021
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients
Fred R Hirsch, Jill Walker, Brandon W Higgs, et al.
Diagnostic Pathology
|
September 4, 2019
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
Magdalena Zajac, Marietta Scott, Marianne Ratcliffe, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Ethnicity & Disease
|
February 5, 2016
The Effects of Job Instability and Financial Strain on C-Reactive Protein in a Sample of Mexican Immigrants
Patrick R Steffen, Jill Walker, Richard Meredith, et al.
Open Research Europe
|
April 24, 2024
Machine vision situations: Tracing distributed agency
Marianne Gunderson, Ragnhild Solberg, Linda Kronman, et al.
Plos One
|
June 24, 2014
Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour
James L Sherwood, Susanne Müller, Maria C M Orr, et al.
The Journal of General Virology
|
September 3, 2013
Pharmacological disruption of hepatitis C NS5A protein intra- and intermolecular conformations
Dipankar Bhattacharya, Israrul H Ansari, Robert Hamatake, et al.
Diagnostic Pathology
|
July 26, 2018
Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay
Paul Scorer, Marietta Scott, Nicola Lawson, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody, Yiduo Zhang, Marc Ballas, et al.
Clinical and Translational Science
|
November 26, 2025
Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants
Qianwen Wang, Ahmed Nader, Amanda Peppercorn, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2014
Case series of rash associated with influenza B in school children
Danuta M Skowronski, Catharine Chambers, William Osei, et al.
Clinical Lung Cancer
|
October 14, 2021
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients
Fred R Hirsch, Jill Walker, Brandon W Higgs, et al.
Diagnostic Pathology
|
September 4, 2019
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
Magdalena Zajac, Marietta Scott, Marianne Ratcliffe, et al.
Page
of 7